Delpazolid

• CAT Number: I006020
• CAS Number: 1219707-39-7
• Molecular Formula: C14H17FN4O3
• Molecular Weight: 308.3134
• Purity: ≥95%
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term ,or -20 °C for long term
• IUPAC Name: (5R)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
• InChI: InChI=1S/C14H17FN4O3/c1-17-4-5-18(9-16-17)13-3-2-10(6-12(13)15)19-7-11(8-20)22-14(19)21/h2-3,6,9,11,20H,4-5,7-8H2,1H3/t11-/m1/s1
• InChIKey: QLUWQAFDTNAYPN-LLVKDONJSA-N
• SMILES: O=C1O[C@@H](CO)CN1C2=CC=C(N3C=NN(C)CC3)C(F)=C2

Delpazolid(CAT: I006020) is a synthetic compound that belongs to the class of oxazolidinone antibiotics. Delpazolid works by inhibiting bacterial protein synthesis, specifically by binding to the 50S ribosomal subunit of the bacteria and preventing the formation of functional 70S ribosomes. This leads to the inhibition of bacterial growth and the eventual death of the bacteria. Delpazolid has shown activity against a variety of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). It is being developed as a potential treatment for infections caused by these bacteria.